Beverly, MA – According to filings with the U.S. Securities and Exchange Commission, LeviSense Medical is raising $3,249,994.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Bertoni played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About LeviSense Medical
LeviSense Medical, Inc. will transform the therapeutic bed market for the prevention and treatment of complex pressure injuries (also know as pressure ulcers or bed sores). LeviSense Medical has developed an instrumented bed system with, high-resolution sensing and surface control. The system scans the patients form, position, and movements several times per second and adjusts the surface to protect the patient from excessive pressure that causes bed sores – automatically, with no caregiver intervention! LeviSense technology is at the center of the mega trends in healthcare: telehealth, IOT and better clinical outcomes through patient data and technology. Current solutions rely on pressure redistribution mattresses, which have changed little over the decades, so patients require frequent repositioning by the nursing staff that adds to hospital labor costs and results in unnecessary risks of additional injury to the patient as well as injury to the caregiver. The LeviSense system is a fundamental advance on existing technology and has application beyond beds in institutional settings, opening an enormous addressable market.

To learn more about LeviSense Medical, visit http://levisensemedical.com/

Contact:
David Bertoni, Chief Executive Officer
978-338-4104
david@levisensemedical.com
https://www.linkedin.com/in/david-w-bertoni-1502b84/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved